KARA SPALIK: Open Payments
NPI 1306277017 · JOHNSON CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,771 in 175 payments from 42 companies in 2025. Trend: 2023 $3,720 · 2024 $4,473 · 2025 $3,771
Food & beverage: $3,771
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $363 |
| ABBVIE INC. | 14 | $318 |
| Novartis Pharmaceuticals Corporation | 13 | $261 |
| Daiichi Sankyo Inc. | 12 | $224 |
| Gilead Sciences, Inc. | 5 | $211 |
| PFIZER INC. | 14 | $202 |
| Eisai Inc. | 8 | $180 |
| Merck Sharp & Dohme LLC | 9 | $150 |
| E.R. Squibb & Sons, L.L.C. | 8 | $145 |
| Immunocore Limited | 1 | $143 |
Products named: Trodelvy, Lenvima, CALQUENCE, KIMMTRAK, KEYTRUDA, ELIQUIS, EPKINLY, ELAHERE.
Industry payments across NY — which companies pay providers there.
